CHARLES K. MCSHERRY, M.D.
This content is PDF only. Please click on the PDF icon to access.
It is difficult to comment on the long-awaited report (1) of the close to $11 million study of the effectiveness of chenodiol (chenodeoxycholic acid) to dissolve cholesterol gallstones without incorporating some elements of personal prejudice. This prejudice is born of a career-long interest in promoting and documenting the efficacy and safety of surgery for calculous biliary tract disease. In the final analysis, the success or failure of chenodiol therapy must be judged against the standard of surgical accomplishment, cholecystectomy.
Over the past 4 decades, Dr. Frank Glenn has accumulated an institutional experience of almost 15 000 patients treated surgically for
MCSHERRY CK. The National Cooperative Gallstone Study Report: A Surgeon's Perspective. Ann Intern Med. ;95:379–380. doi: 10.7326/0003-4819-95-3-379
Download citation file:
Published: Ann Intern Med. 1981;95(3):379-380.
Biliary Disorders, Gastroenterology/Hepatology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use